Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2015 Jul 26;21(12):2136–2140. doi: 10.1016/j.bbmt.2015.07.018

Table 2.

Response

Best response
to BV, N=37
Response to combination chemotherapy
(ICE/DICE/IGEV/GND) post-BV, N=18
Disease Status at
AHCT, N=33
ORR 25/37 (68%) 16/18 (89%)
CR 13/37 (35%) 11/18 (61%) 24/33 (73%)
PR 12/37 (32%) 5/18 (28%) 9/33 (27%)
SD 10/37 (27%) 1/18 (6%) 1/33 (3%)
PD 2/37 (5%) 1/18 (6%)